Hypoxia in murine atherosclerotic plaques and its adverse effects on macrophages

Saj Parathath1, Yuan Yang, Stephanie Mick

  • 1Department of Medicine (Cardiology), Marc and Ruti Bell Program in Vascular Biology, NYU School of Medicine, Smilow 7, 522 First Ave., New York, NY 10016, USA.

Insights

Hypoxia, or low oxygen, is confirmed in mouse models of atherosclerosis. This condition impacts lipid synthesis and cholesterol transport, with HIF-1α playing a key role.

Area of Science:

  • Cardiovascular Biology
  • Atherosclerosis Research
  • Hypoxia Studies

Background:

  • Hypoxia is present in human atherosclerotic plaques.
  • The occurrence of hypoxia in mouse models of atherosclerosis has been debated due to their small size.

Purpose of the Study:

  • To review evidence confirming hypoxia in apolipoprotein E-deficient (apoE-/-) mouse models.
  • To explore the in vitro effects of hypoxia on lipid metabolism and cholesterol efflux.
  • To investigate the role of HIF-1α in mediating these hypoxic effects.

Main Methods:

  • Review of a recent report on hypoxia detection in apoE-/- mouse plaques.
  • In vitro experiments assessing lipid synthesis and cholesterol efflux.
  • Analysis of the involvement of the transcription factor HIF-1α.

Main Results:

  • Direct evidence of hypoxia was found in atherosclerotic plaques of apoE-/- mice.
  • In vitro, hypoxia increased lipid synthesis and decreased cholesterol efflux via the ABCA1 pathway.
  • HIF-1α mediated a significant portion, but not all, of these hypoxia-induced changes.

Conclusions:

  • Hypoxia is demonstrable in mouse models of atherosclerosis, validating their use in research.
  • Hypoxia influences key cellular processes in atherosclerosis, including lipid metabolism and cholesterol transport.
  • Findings provide insights into the pathophysiology of atherosclerosis and potential therapeutic targets.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Inflammation01:38

Inflammation

Overview
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...